These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 20654563

  • 1. Chromium (VI)-induced cytotoxicity to osteoblast-derived cells.
    Ning J, Grant MH.
    Toxicol In Vitro; 1999 Dec; 13(6):879-87. PubMed ID: 20654563
    [Abstract] [Full Text] [Related]

  • 2. The role of reduced glutathione and glutathione reductase in the cytotoxicity of chromium (VI) in osteoblasts.
    Ning J, Grant MH.
    Toxicol In Vitro; 2000 Aug; 14(4):329-35. PubMed ID: 10906439
    [Abstract] [Full Text] [Related]

  • 3. The role of glutathione reductase in the cytotoxicity of chromium (VI) in isolated rat hepatocytes.
    Gunaratnam M, Grant MH.
    Chem Biol Interact; 2001 Apr 16; 134(2):191-202. PubMed ID: 11311213
    [Abstract] [Full Text] [Related]

  • 4. Pretreatment of rats with the inducing agents phenobarbitone and 3-methylcholanthrene ameliorates the toxicity of chromium (VI) in hepatocytes.
    Gunaratnam M, Pohlscheidt M, Grant MH.
    Toxicol In Vitro; 2002 Oct 16; 16(5):509-16. PubMed ID: 12206817
    [Abstract] [Full Text] [Related]

  • 5. The interaction of chromium (VI) with macrophages: depletion of glutathione and inhibition of glutathione reductase.
    Lalaouni A, Henderson C, Kupper C, Grant MH.
    Toxicology; 2007 Jul 01; 236(1-2):76-81. PubMed ID: 17498860
    [Abstract] [Full Text] [Related]

  • 6. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
    Poljsak B, Gazdag Z, Jenko-Brinovec S, Fujs S, Pesti M, Bélagyi J, Plesnicar S, Raspor P.
    J Appl Toxicol; 2005 Jul 01; 25(6):535-48. PubMed ID: 16092082
    [Abstract] [Full Text] [Related]

  • 7. Cr (VI) inhibits DNA, RNA and protein syntheses in hepatocytes: involvement of glutathione reductase, reduced glutathione and DT-diaphorase.
    Gunaratnam M, Grant MH.
    Toxicol In Vitro; 2008 Jun 01; 22(4):879-86. PubMed ID: 18321676
    [Abstract] [Full Text] [Related]

  • 8. Heme-oxygenase 1 gene expression is a marker for hexavalent chromium-induced stress and toxicity in human dermal fibroblasts.
    Joseph P, He Q, Umbright C.
    Toxicol Sci; 2008 Jun 01; 103(2):325-34. PubMed ID: 18332044
    [Abstract] [Full Text] [Related]

  • 9. Interactions of orthopaedic metals with an immortalized rat osteoblast cell line.
    McKay GC, Macnair R, MacDonald C, Grant MH.
    Biomaterials; 1996 Jul 01; 17(13):1339-44. PubMed ID: 8805983
    [Abstract] [Full Text] [Related]

  • 10. Biological reactive intermediates that mediate chromium (VI) toxicity.
    Pourahmad J, O'Brien PJ.
    Adv Exp Med Biol; 2001 Jul 01; 500():203-7. PubMed ID: 11764936
    [Abstract] [Full Text] [Related]

  • 11. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats.
    Standeven AM, Wetterhahn KE.
    Pharmacol Toxicol; 1991 Jun 01; 68(6):469-76. PubMed ID: 1891442
    [Abstract] [Full Text] [Related]

  • 12. In vivo nephrotoxicity induced in mice by chromium(VI). Involvement of glutathione and chromium(V).
    Hojo Y, Satomi Y.
    Biol Trace Elem Res; 1991 Oct 01; 31(1):21-31. PubMed ID: 1724173
    [Abstract] [Full Text] [Related]

  • 13. The reduction of chromium (VI) to chromium (III) by glutathione: an intracellular redox pathway in the metabolism of the carcinogen chromate.
    Wiegand HJ, Ottenwälder H, Bolt HM.
    Toxicology; 1984 Dec 01; 33(3-4):341-8. PubMed ID: 6515663
    [Abstract] [Full Text] [Related]

  • 14. The interaction of the orthopaedic metals, chromium VI and nickel, with hepatocytes.
    Gunaratnam M, Grant MH.
    J Mater Sci Mater Med; 2001 Dec 01; 12(10-12):945-8. PubMed ID: 15348345
    [Abstract] [Full Text] [Related]

  • 15. Effect of glutathione depletion on formation of paramagnetic chromium in Chinese hamster V-79 cells.
    Sugiyama M, Tsuzuki K.
    FEBS Lett; 1994 Mar 21; 341(2-3):273-6. PubMed ID: 8137952
    [Abstract] [Full Text] [Related]

  • 16. Two pathways for chromium(VI)-induced DNA damage in 14 day chick embryos: Cr-DNA binding in liver and 8-oxo-2'-deoxyguanosine in red blood cells.
    Misra M, Alcedo JA, Wetterhahn KE.
    Carcinogenesis; 1994 Dec 21; 15(12):2911-7. PubMed ID: 8001255
    [Abstract] [Full Text] [Related]

  • 17. Formation of paramagnetic chromium in liver of mice treated with dichromate (VI).
    Ueno S, Susa N, Furukawa Y, Sugiyama M.
    Toxicol Appl Pharmacol; 1995 Dec 21; 135(2):165-71. PubMed ID: 8545823
    [Abstract] [Full Text] [Related]

  • 18. Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved?
    Aiyar J, De Flora S, Wetterhahn KE.
    Carcinogenesis; 1992 Jul 21; 13(7):1159-66. PubMed ID: 1379126
    [Abstract] [Full Text] [Related]

  • 19. Effect of chromium (VI) exposure on antioxidant defense status and trace element homeostasis in acute experiment in rat.
    Kotyzová D, Hodková A, Bludovská M, Eybl V.
    Toxicol Ind Health; 2015 Nov 21; 31(11):1044-50. PubMed ID: 23625905
    [Abstract] [Full Text] [Related]

  • 20. The cytotoxicity of chromium in osteoblasts: effects on macromolecular synthesis.
    Ning J, Henderson C, Grant MH.
    J Mater Sci Mater Med; 2002 Jan 21; 13(1):47-52. PubMed ID: 15348204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.